That BAP1 expression lacks prognostic impact in cancers with identical quantitative Gleason grade demonstrates the statistical power of the quantitative Gleason grading system, however, it is not universally applied and does not solve all issues of interobserver variability in PCa grading. The gene discussed is BAP1; the disease is posterior cortical atrophy.